ロード中...
The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin‐6 and C‐reactive protein by modelling
AIMS: Early identification of patients with febrile neutropenia (FN) is desirable for initiation of preventive treatment, such as with antibiotics. In this study, the time courses of two inflammation biomarkers, interleukin (IL)‐6 and C‐reactive protein (CRP), following adjuvant chemotherapy of brea...
保存先:
| 出版年: | Br J Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5809342/ https://ncbi.nlm.nih.gov/pubmed/29178353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13477 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|